![](/img/cover-not-exists.png)
ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease
Stone, D J, Molony, C, Suver, C, Schadt, E E, Potter, W ZVolume:
10
Language:
english
Journal:
The Pharmacogenomics Journal
DOI:
10.1038/tpj.2009.58
Date:
June, 2010
File:
PDF, 195 KB
english, 2010